Literature DB >> 33279272

RB1 loss induced small cell lung cancer transformation as acquired resistance to pembrolizumab in an advanced NSCLC patient.

Sayaka Arakawa1, Tatsuya Yoshida2, Masayuki Shirasawa1, Daisuke Takayanagi3, Shigehiro Yagishita4, Noriko Motoi5, Yuichiro Ohe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33279272     DOI： 10.1016/j.lungcan.2020.11.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  2 in total

1.  Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes.

Authors:  Olga Y Gorlova; Marek Kimmel; Spiridon Tsavachidis; Christopher I Amos; Ivan P Gorlov
Journal:  Oncotarget       Date:  2022-05-25

2.  Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma.

Authors:  Shuo Hong; Yueming Zhang; Manming Cao; Anqi Lin; Qi Yang; Jian Zhang; Peng Luo; Linlang Guo
Journal:  Front Cell Dev Biol       Date:  2021-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.